TNFSF13B
Tumor necrosis factor ligand superfamily member 13B
Also known as: BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TN13B_HUMAN, TNFSF20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y275
- Gene
- TNFSF13B
- Ensembl
- ENSG00000102524
- Chromosome
- 13
- Canonical length
- 285 aa
- Protein class
- Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Vesicles,Plasma membrane,Focal adhesion sites
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. This cytokine is expressed in B cell lineage cells, and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
285 residues, UniProt reviewed canonical sequence.
>Q9Y275|TNFSF13B
1 MDDSTEREQS RLTSCLKKRE EMKLKECVSI LPRKESPSVR SSKDGKLLAA TLLLALLSCC
61 LTVVSFYQVA ALQGDLASLR AELQGHHAEK LPAGAGAPKA GLEEAPAVTA GLKIFEPPAP
121 GEGNSSQNSR NKRAVQGPEE TVTQDCLQLI ADSETPTIQK GSYTFVPWLL SFKRGSALEE
181 KENKILVKET GYFFIYGQVL YTDKTYAMGH LIQRKKVHVF GDELSLVTLF RCIQNMPETL
241 PNNSCYSAGI AKLEEGDELQ LAIPRENAQI SLDGDVTFFG ALKLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFSF13B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 24 nTPM
Expression across tissuesHPA
Tissue
- appendix: 24 nTPM
- lymph node: 20 nTPM
- bone marrow: 19 nTPM
- tonsil: 17 nTPM
- spleen: 15 nTPM
- gallbladder: 12 nTPM
Single-cell type
- neutrophils: 420 nCPM
- monocytes: 258 nCPM
- cdc: 219 nCPM
- monocyte progenitors: 202 nCPM
- kupffer cells: 189 nCPM
- choroid plexus epithelial cells: 144 nCPM
Immune cell
- neutrophil: 509 nTPM
- classical monocyte: 352 nTPM
- intermediate monocyte: 273 nTPM
- non-classical monocyte: 236 nTPM
- myeloid DC: 207 nTPM
- total PBMC: 166 nTPM
Brain region
- medulla oblongata: 11 nTPM
- choroid plexus: 9.7 nTPM
- white matter: 8.5 nTPM
- spinal cord: 7.6 nTPM
- pons: 6.6 nTPM
- cerebral cortex: 5.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.14
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell costimulation
- B cell homeostasis
- B cell proliferation
- germinal center formation
- immune response
- lymphocyte homeostasis
- positive regulation of B cell proliferation
- positive regulation of germinal center formation
- positive regulation of T cell proliferation
- signal transduction
- skin development
- T cell costimulation
- T cell proliferation
- transitional one stage B cell differentiation
- tumor necrosis factor-mediated signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFSF13B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFSF13B as an antibody target. Whether an autoantibody or antibody against TNFSF13B could matter depends on whether native TNFSF13B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFSF13B is annotated at the cell surface, where native TNFSF13B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFSF13B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...